10122-510Level 3
Curosurf (poractant alfa)
**Product type:** Human Prescription Drug
**Active ingredient:** PORACTANT ALFA
**Strength:** 80 mg/mL
**Dosage form:** Suspension
**Route:** Endotracheal
**Labeler:** Chiesi USA, Inc.
**Marketing category:** BLA (BLA020744)
**Pharmacologic class:** Alveolar Surface Tension Reduction [PE], Surfactant Activity [MoA], Surfactant [EPC]
GET
/api/v1/systems/ndc_fda/nodes/10122-510Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.